Evidence map›Paper›PMID 26446877›Full record

ArticleImmunology and cell biology2016

Perforin facilitates beta cell killing and regulates autoreactive CD8+ T-cell responses to antigen in mouse models of type 1 diabetes.

Prerak Trivedi, Kate L Graham, Balasubramaninan Krishnamurthy, Stacey Fynch, Robyn M Slattery, Thomas W H Kay, Helen E Thomas

Abstract read
PubMed Publisher
In one paragraph

Article in Immunology and cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Prerak TrivediImmunology and Diabetes, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
Kate L GrahamImmunology and Diabetes, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
Balasubramaninan KrishnamurthyImmunology and Diabetes, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
Stacey FynchImmunology and Diabetes, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
Robyn M SlatteryDepartment of Immunology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Alfred Hospital, Prahran, Victoria, Australia.
Thomas W H KayImmunology and Diabetes, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
Helen E ThomasImmunology and Diabetes, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
St Vincent's Hospital · AUSt Vincents Institute of Medical Research · AUMonash Alfred Psychiatry Research centre · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In type 1 diabetes, cytotoxic CD8(+) T lymphocytes (CTLs) directly interact with pancreatic beta cells through major histocompatibility complex class I. An immune synapse facilitates delivery of cytotoxic granules, comprised mainly of granzymes and perforin. Perforin deficiency protects the majority of non-obese diabetic (NOD) mice from autoimmune diabetes. Intriguingly perforin deficiency does not prevent diabetes in CD8(+) T-cell receptor transgenic NOD8.3 mice. We therefore investigated the importance of perforin-dependent killing via CTL-beta cell contact in autoimmune diabetes. Perforin-deficient CTL from NOD mice or from NOD8.3 mice were significantly less efficient at adoptive transfer of autoimmune diabetes into NODRag1(-/-) mice, confirming that perforin is essential to facilitate beta cell destruction. However, increasing the number of transferred in vitro-activated perforin-deficient 8.3 T cells reversed the phenotype and resulted in diabetes. Perforin-deficient NOD8.3 T cells were present in increased proportion in islets, and proliferated more in response to antigen in vivo indicating that perforin may regulate the activation of CTLs, possibly by controlling cytokine production. This was confirmed when we examined the requirement for direct interaction between beta cells and CD8(+) T cells in NOD8.3 mice, in which beta cells specifically lack major histocompatibility complex (MHC) class I through conditional deletion of β2-microglobulin. Although diabetes was significantly reduced, 40% of these mice developed diabetes, indicating that NOD8.3 T cells can kill beta cells in the absence of direct interaction. Our data indicate that although perforin delivery is the main mechanism that CTL use to destroy beta cells, they can employ alternative mechanisms to induce diabetes in a perforin-independent manner.

Indexed as

Cytotoxicity, ImmunologicAnimalsAutoantigensCD8-Positive T-LymphocytesCells, CulturedDiabetes Mellitus, Type 1Disease Models, AnimalHumansInsulin-Secreting CellsLymphocyte ActivationMiceMice, Inbred NODMice, KnockoutParacrine CommunicationPerforinAutoantigensPerforin

Identifiers

PMID26446877
OpenAlexW2340574241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.